| Aug 1, 2025 |
Aug 5, 2025 |
Aurinia Pharmaceuticals Inc.
|
Director |
Buy |
100.0
|
+1,300,000
|
12.96%
|
✗
|
$13.6M |
| Feb 28, 2025 |
Mar 4, 2025 |
Aurinia Pharmaceuticals Inc.
|
Director |
Buy |
100.0
|
+1,600,000
|
18.98%
|
✗
|
$12.7M |
| Dec 5, 2024 |
Dec 9, 2024 |
Aurinia Pharmaceuticals Inc.
|
Director |
Buy |
100.0
|
+1,200,000
|
16.60%
|
✗
|
$10.8M |
| Nov 23, 2021 |
Nov 26, 2021 |
Aptevo Therapeutics Inc.
|
Other |
Sell |
15.0
|
-921,336
|
-100.00%
|
✗
|
$10.4M |
| Nov 18, 2021 |
Nov 22, 2021 |
Aptevo Therapeutics Inc.
|
10% Owner |
Sell |
16.3
|
-838,664
|
-47.65%
|
✗
|
$6.5M |
| Nov 4, 2020 |
Nov 6, 2020 |
Aptevo Therapeutics Inc.
|
10% Owner |
Buy |
100.0
|
+1,436,675
|
444.34%
|
✗
|
$24.8M |
| Oct 4, 2019 |
Oct 7, 2019 |
HERON THERAPEUTICS, INC. /DE/
|
Director |
Buy |
95.0
|
+285,714
|
5.16%
|
✗
|
$5M |
| Sep 12, 2018 |
Sep 12, 2018 |
HERON THERAPEUTICS, INC. /DE/
|
Director |
Sell |
15.0
|
-2,695,000
|
-31.53%
|
✗
|
$96.3M |
| Mar 29, 2018 |
Apr 2, 2018 |
HERON THERAPEUTICS, INC. /DE/
|
Director |
Buy |
88.8
|
+192,308
|
2.30%
|
✗
|
$5M |
| Feb 23, 2017 |
Feb 27, 2017 |
Cyclacel Pharmaceuticals, Inc.
|
10% Owner |
Buy |
97.5
|
+134,200
|
31.52%
|
✗
|
$582.1K |
| Jan 19, 2017 |
Jan 23, 2017 |
HERON THERAPEUTICS, INC. /DE/
|
Director |
Buy |
100.0
|
+2,459,016
|
41.71%
|
✗
|
$30M |
| Jun 16, 2016 |
Jun 20, 2016 |
HERON THERAPEUTICS, INC. /DE/
|
Director |
Sell |
17.5
|
-243,639
|
-3.97%
|
✗
|
$4.5M |
| Jun 10, 2015 |
Jun 12, 2015 |
HERON THERAPEUTICS, INC. /DE/
|
Director |
Buy |
92.5
|
+121,212
|
2.54%
|
✗
|
$3M |
| May 29, 2015 |
Jun 2, 2015 |
HERON THERAPEUTICS, INC. /DE/
|
Director |
Buy |
92.5
|
+150,000
|
3.25%
|
✗
|
$3.1M |
| Jun 25, 2014 |
Jun 27, 2014 |
HERON THERAPEUTICS, INC. /DE/
|
Director |
Buy |
100.0
|
+510,638
|
12.43%
|
✗
|
$6M |
| Jan 14, 2010 |
Jan 19, 2010 |
Vanda Pharmaceuticals Inc.
|
10% Owner |
Sell |
20.0
|
-54,900
|
-1.98%
|
✗
|
$589.2K |
| Jan 11, 2010 |
Jan 13, 2010 |
Vanda Pharmaceuticals Inc.
|
10% Owner |
Sell |
17.5
|
-149,600
|
-5.12%
|
✗
|
$1.6M |
| Jan 4, 2010 |
Jan 6, 2010 |
Vanda Pharmaceuticals Inc.
|
10% Owner |
Sell |
17.5
|
-145,500
|
-4.75%
|
✗
|
$1.7M |
| Oct 13, 2009 |
Oct 15, 2009 |
Vanda Pharmaceuticals Inc.
|
10% Owner |
Sell |
16.3
|
-600,000
|
-16.37%
|
✗
|
$7.6M |
| Nov 20, 2008 |
Dec 2, 2008 |
Vanda Pharmaceuticals Inc.
|
10% Owner |
Buy |
87.5
|
+145,000
|
4.12%
|
✗
|
$105.5K |
| Nov 7, 2008 |
Nov 12, 2008 |
Vanda Pharmaceuticals Inc.
|
10% Owner |
Buy |
97.5
|
+560,000
|
18.91%
|
✗
|
$464.3K |
| Sep 25, 2008 |
Sep 29, 2008 |
Vanda Pharmaceuticals Inc.
|
10% Owner |
Buy |
97.5
|
+600,000
|
11.95%
|
✗
|
$622.7K |
| Sep 23, 2008 |
Sep 25, 2008 |
Vanda Pharmaceuticals Inc.
|
10% Owner |
Buy |
82.5
|
+80,000
|
1.62%
|
✗
|
$78.5K |
| Sep 22, 2008 |
Sep 24, 2008 |
Vanda Pharmaceuticals Inc.
|
10% Owner |
Buy |
82.5
|
+100,000
|
2.07%
|
✗
|
$99.9K |
| Sep 19, 2008 |
Sep 23, 2008 |
Vanda Pharmaceuticals Inc.
|
10% Owner |
Buy |
100.0
|
+1,080,852
|
28.76%
|
✗
|
$1.1M |